<p>Summary of subanalyses comparing NSAIDs vs. placebo in reducing the number of patients with PEP according to: type of NSAID, route and time of administration and patients inclusion criteria.</p
Objectives The aim was to compare continuous and on-demand NSAID treatment with respect to their abi...
Predefined clinical subgroup analysis with expulsion rate comparing silodosin with tamsulosin.</p
<p><i>CI,</i> confidence interval; <i>M-H</i>, Mantel-Haenszel; <i>NSAIDs</i>, non-steroidal anti-in...
<p>Summary of RCTs which demonstrated treatment superior to placebo, for which Relative Risk and Num...
The selection and use of nonsteroidal anti-inflammatory drugs (NSAIDs) is complicated by the introdu...
Patient demographics and baseline characteristics for fish oil versus placebo and separately for the...
<p>Odds ratios higher than 1 reflect a higher discontinuation rate due to adverse events in the subs...
<p>Funnel plot of the meta-analysis comparing placebo with standard-dose statin treatment.</p
Comparison of Opioid Agonist Treatment related characteristics between non-injecting and injecting d...
<p>The total number of patients enrolled before randomization was used for the analysis of each stud...
<p>Meta-analysis of differences in PLMI between rotigotine and placebo treatments.</p
PURPOSE: A summary of the basic science underlying the current controversies regarding cyclooxygenas...
Comparison of pharmacological data between patients with and without polypharmacy.</p
Objectives: To discuss nonsteroidal anti-inflammatory drugs (NSAIDs), their history, development, mo...
<p>AE, adverse event; SAE, serious adverse event; NA, not applicable.</p><p>Summary of safety outcom...
Objectives The aim was to compare continuous and on-demand NSAID treatment with respect to their abi...
Predefined clinical subgroup analysis with expulsion rate comparing silodosin with tamsulosin.</p
<p><i>CI,</i> confidence interval; <i>M-H</i>, Mantel-Haenszel; <i>NSAIDs</i>, non-steroidal anti-in...
<p>Summary of RCTs which demonstrated treatment superior to placebo, for which Relative Risk and Num...
The selection and use of nonsteroidal anti-inflammatory drugs (NSAIDs) is complicated by the introdu...
Patient demographics and baseline characteristics for fish oil versus placebo and separately for the...
<p>Odds ratios higher than 1 reflect a higher discontinuation rate due to adverse events in the subs...
<p>Funnel plot of the meta-analysis comparing placebo with standard-dose statin treatment.</p
Comparison of Opioid Agonist Treatment related characteristics between non-injecting and injecting d...
<p>The total number of patients enrolled before randomization was used for the analysis of each stud...
<p>Meta-analysis of differences in PLMI between rotigotine and placebo treatments.</p
PURPOSE: A summary of the basic science underlying the current controversies regarding cyclooxygenas...
Comparison of pharmacological data between patients with and without polypharmacy.</p
Objectives: To discuss nonsteroidal anti-inflammatory drugs (NSAIDs), their history, development, mo...
<p>AE, adverse event; SAE, serious adverse event; NA, not applicable.</p><p>Summary of safety outcom...
Objectives The aim was to compare continuous and on-demand NSAID treatment with respect to their abi...
Predefined clinical subgroup analysis with expulsion rate comparing silodosin with tamsulosin.</p
<p><i>CI,</i> confidence interval; <i>M-H</i>, Mantel-Haenszel; <i>NSAIDs</i>, non-steroidal anti-in...